Category: Health & Medicines > Health Care Supplement > Dolutegravir
Country/Region: China State/Province: Hubei
Main Products: Pharmaceutical Raw Materials
Business Type: Manufacturer, Buying House
Year Established: 2009
Employees: 51 - 100 People
Plant Area: 3,000-5,000 square meters
Main Markets: South America 11% Africa 8% Eastern Asia 12% Domestic Market 10% North America 9% Eastern Europe 11% Southern Europe 8% Mid East 10% Northern Europe 11% Oceania 10%
Trade Capacity: FOB, CIF, Express Delivery
Contract Manufacturing: OEM Service Offered Design Service Offered Buyer Label Offered
Nearest Port: Wuhan
Annual Revenue: US$50 Million - US$100 Million
Total Revenue: Below US$1 Million
Export Revenue: US$1 Million - US$2.5 Million
Annual Output: US$50 Million - US$100 Million
Registered Capital: US$50 Million - US$100 Million
Export Percentage: 21% - 30%
Payment Modes: USD, CAD, CHF
Lead Time: 5 days
Import/Export Mode: Have Own Export License